Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Woitalla

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical Neuropharmacology|June 4, 2008
Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson diseaseThomas Müller, Kira Kolf, Lema Ander, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2015
Epitope Mapping Using Peptide Microarray in Autoantibody ProfilingSebastian Henkel, Robert Wellhausen, Dirk Woitalla, et al.
Neuroepidemiology|November 29, 2007
The management approaches to dyskinesia vary from country to countryDirk Woitalla, Thomas Mueller, Hermann Russ, et al.
Neuroscience Letters|June 9, 2004
Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's diseaseSiegfried Muhlack, Dirk Woitalla, Jacob Welnic, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2006
Entacapone improves complex movement performance in patients with Parkinson's diseaseThomas Müller, Christoph Erdmann, Siegfried Muhlack, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 21, 2017
Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential TremorDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2005
Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levelsThomas Müller, Christoph Erdmann, Siegfried Muhlack, et al.
Neurobiology of Aging|January 19, 2016
Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's diseaseRichard Wüst, Brigitte Maurer, Kathrin Hauser, et al.
Frontiers in Neurology|August 23, 2018
Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease PatientsDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Neuroscience Letters|June 8, 2002
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's diseaseThorsten Schulte, Ludger Schöls, Thomas Müller, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical Neuropharmacology|June 4, 2008
Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson diseaseThomas Müller, Kira Kolf, Lema Ander, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2015
Epitope Mapping Using Peptide Microarray in Autoantibody ProfilingSebastian Henkel, Robert Wellhausen, Dirk Woitalla, et al.
Neuroepidemiology|November 29, 2007
The management approaches to dyskinesia vary from country to countryDirk Woitalla, Thomas Mueller, Hermann Russ, et al.
Neuroscience Letters|June 9, 2004
Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's diseaseSiegfried Muhlack, Dirk Woitalla, Jacob Welnic, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2006
Entacapone improves complex movement performance in patients with Parkinson's diseaseThomas Müller, Christoph Erdmann, Siegfried Muhlack, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 21, 2017
Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential TremorDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2005
Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levelsThomas Müller, Christoph Erdmann, Siegfried Muhlack, et al.
Neurobiology of Aging|January 19, 2016
Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's diseaseRichard Wüst, Brigitte Maurer, Kathrin Hauser, et al.
Frontiers in Neurology|August 23, 2018
Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease PatientsDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Neuroscience Letters|June 8, 2002
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's diseaseThorsten Schulte, Ludger Schöls, Thomas Müller, et al.
Pageof 7